Nikolaos Tsoulos

Nikolaos Tsoulos studied Biochemistry at the State University of New York at Stony Brook, graduating with distinction. He then worked as a Biochemist at Capital Genomics Inc.’s research lab in Maryland, USA.

As CEO of Genekor M.S.A., Nikolaos Tsoulos founded the company, created the sales and marketing departments, and simultaneously established international collaborations with some of the largest companies in the field (Oncotype DX, Foundation One, Signatera, and Avantect). Additionally, he developed a network of partner laboratories across Europe, the Middle East, and the Balkans and established subsidiaries in seven European countries (Turkey, Romania, Latvia, Estonia, Lithuania, Czech Republic, and Slovakia). Through these efforts, he achieved the provision of molecular analyses with a focus on high quality, accessibility, reliability, and prompt results.

Nikolaos Tsoulos has also served as Vice President of the non-profit Research Institute of Individualized Medicine for Cancer, specializing in personalized cancer medicine.